Phase I study of DK049 in tumour patients

Trial Profile

Phase I study of DK049 in tumour patients

Phase of Trial: Phase I

Latest Information Update: 05 Jan 2016

At a glance

  • Drugs DK 049 (Primary)
  • Indications Tumours
  • Focus Adverse reactions
  • Sponsors CytRx Corporation
  • Most Recent Events

    • 05 Jan 2016 According to CytRx media release, DK049 is expected to enter clinical trials in 2016.
    • 09 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top